Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results

Go back to Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
(NASDAQ: MRNS) Delayed: 0.55 --0 (-0%)
Previous Close $0.55    52 Week High $8.12 
Open $0.55    52 Week Low $1.02 
Day High $0.55    P/E N/A 
Day Low $0.55    EPS $0.00 
Volume 367,437